Up to 24.2% body weight reduction after 48 weeks has been observed with higher doses in people with obesity
In addition, Lilly will sell the initial dose of its weight-loss pill, Orforglipron, for $149 through TrumpRx if the drug, which is currently being tested, is approved by the Food and Drug Administration.
Study methods: Adult patients who were taking GLP-1s and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS)
Inoue M, Kinne R, Tran T, Arias IM
The rule passed the committee with a positive recommendation, allowing it to move forward in the rulemaking process
Your exact results may vary based on your body and lifestyle